Latest Commercial Expansion News

Page 1 of 19
Swift TV expanded its contracted footprint and qualified pipeline in the September quarter, but ended with $1.047 million in cash and only 0.9 quarters of funding at the reported burn rate. The company is relying on customer receipts, an expected $1.5 million R&D incentive and lending arrangements as commercial deployments accelerate.
Sophie Babbage
Sophie Babbage
30 Oct 2026
Gratifii has put its rebuilt Connect+ Marketplace in front of Qantas, Woolworths MarketPlus and Blackhawk Network, opening distribution channels that reach millions of loyalty members. The commercial momentum came as quarterly cash receipts fell 16.5% and available funding stood at roughly 2.5 quarters.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Electrovaya will invest approximately A$2.0 million in Janus Electric through a proposed placement, while Janus has placed initial battery orders worth about A$37.5 million for its North American truck programme. The investment remains subject to completion conditions, and the battery orders depend on agreed delivery schedules.
Maxwell Dee
Maxwell Dee
28 Oct 2026
Vitrafy has expanded its US blood and cell therapy partnerships while preparing Guardion for a planned medical device listing by the end of 2026. The company ended September with A$38.3 million in cash and term deposits, but expects spending to rise as validation and manufacturing accelerate.
Victor Sage
Victor Sage
28 Oct 2026
Vection Technologies has confirmed a $1.35m FY27 annual revenue order from a classified national security and law enforcement customer, extending a programme that has run continuously for more than five years. The revenue is expected to be fully recognised during FY27, although the customer and contract terms remain undisclosed.
Sophie Babbage
Sophie Babbage
26 Oct 2026
Janus Electric has used a A$1.91 million FY2026 R&D tax refund to cut its Rockford loan balance to A$987,000. The repayment is expected to reduce interest costs by about A$325,000 a year, while a further overseas R&D refund remains subject to approval.
Victor Sage
Victor Sage
20 Oct 2026
Mesoblast has reported a sharp first-quarter commercial improvement, with Ryoncil revenue rising 44% and net operating cash spend falling 85% year on year. The company ended September with US$99 million in cash, although the figures remain preliminary.
Victor Sage
Victor Sage
16 Oct 2026
EBR Systems reported 40 WiSE commercial implants in Q3, down from 46 in Q2 and below its prior forecast, as leadership changes and a sales strategy reset disrupted activity. Higher Medicare reimbursement and progress at its new manufacturing facility offer potential offsets, but both remain dependent on execution and regulatory approval.
Victor Sage
Victor Sage
12 Oct 2026
Memphasys will receive an A$3.5 million advance from major shareholder Peters Investments to expand Felix production, inventory and sales capacity as repeat orders emerge across international markets. The funding carries a 12.5% interest rate, potential equity dilution and requires shareholder and ASX approvals before the convertible notes can be issued.
Ada Torres
Ada Torres
29 Sept 2026
MyEco Group is seeking up to $1.5 million through a discounted, non-underwritten share purchase plan to expand council and waste management sales, retail distribution and its eco-home range. The final issue price and amount raised remain uncertain, with the company retaining the option to scale up the offer or pursue a follow-on placement.
Victor Sage
Victor Sage
23 Sept 2026
EBR Systems plans to file a Changes Being Effected PMA supplement in the fourth quarter to make echo-induced pacing risks and their mitigations more prominent on WiSE System labelling. The FDA has aligned with the proposed path, but the filing and final labelling changes are still ahead.
Victor Sage
Victor Sage
16 Sept 2026
Dataworks has secured firm commitments for a A$3.0 million placement and will seek up to a further A$1.24 million from shareholders to fund debt repayment, government contract mobilisation and commercial expansion. The raise gives the company more capital to pursue growth, but at a discount that will increase the share count and potentially add substantial option dilution.
Sophie Babbage
Sophie Babbage
15 Sept 2026

Browse the archive

Full archive